# testHP

## Biological Monitoring & Longevity Research Platform

`testHP` is a research-oriented project aimed at building a **multimodal system for continuous monitoring of the human organism**. The long-term goal is to understand the biological state of a person at multiple levels, detect abnormalities and ageing-related changes early, track their evolution over time, and eventually evaluate whether interventions preserve or restore biological function.

> **Vision:** build a system capable of monitoring the human body as a dynamic biological system rather than reducing health to a single number or diagnosis.

The long-term research ambition is to investigate how biological function could be maintained for an exceptionally long time, potentially including a 200-year human lifespan. This is a research goal, not a current capability or a medical claim.

---

## What problem is this project trying to solve?

The project treats long-term health as two interacting problems:

1. **Ageing** — gradual changes in cells, tissues, organs and biological systems that reduce function over time.
2. **Pathology** — diseases, infections, inflammation, cancer, injury and other events that can occur at any age.

The system should monitor both simultaneously.

A simplified view is:

```text
                         HUMAN ORGANISM
                                |
                +---------------+---------------+
                |                               |
             AGEING                          PATHOLOGY
                |                               |
        cellular changes                 disease processes
        tissue degeneration              inflammation
        molecular changes                infection
        functional decline               cancer
                |                               |
                +---------------+---------------+
                                |
                         BIOLOGICAL STATE
                                |
                     risk / anomaly / trend
                                |
                       next measurement
                                |
                         state is updated
```

---

## Multimodal monitoring

Different parts of the human body require different measurement technologies. The project therefore should not assume that one sensor or one model can describe the entire organism.

Examples include:

- **MRI** for structures such as the brain, joints and bones;
- **microscopy** for skin or cellular morphology;
- **histopathology** for tissue architecture;
- **cell segmentation** for analysing individual cells and populations;
- **RNA / transcriptomics** for molecular state;
- **proteomics and metabolomics** as future molecular modalities;
- **blood and laboratory measurements**;
- **physiological and wearable data**;
- other specialised imaging and diagnostic instruments as the project evolves.

The architecture should allow a new measurement device to be added without redesigning the entire system.

```text
 MRI -----------+
 microscopy -----+
 histology ------+
 single-cell ----+----> modality-specific analysis
 RNA ------------+             |
 blood ----------+             v
 wearables ------+       biological features
                              |
                              v
                     multimodal integration
                              |
                              v
                      biological state
```

---

## Biological state instead of one health score

A central design principle is to avoid reducing the organism to a single value such as:

```text
biological_age = 52
```

Instead, the system should maintain a structured representation of biological state.

For example:

```text
Person
 |
 +-- Nervous system
 |     +-- neuronal integrity
 |     +-- vascular state
 |     +-- inflammation
 |     +-- functional markers
 |
 +-- Cardiovascular system
 |     +-- cardiac function
 |     +-- vascular integrity
 |
 +-- Skeletal system
 |     +-- bone density
 |     +-- microarchitecture
 |
 +-- Skin
 |     +-- cellular state
 |     +-- extracellular matrix
 |
 +-- Immune system
 |     +-- immune state
 |     +-- inflammatory state
 |
 +-- Molecular state
       +-- RNA
       +-- proteins
       +-- metabolites
```

Every observation should ideally contain not only a value, but also:

- measurement time;
- anatomical location;
- measurement modality;
- model/version used for analysis;
- data quality;
- uncertainty/confidence;
- provenance/source;
- relationship to previous observations.

This is important because biological measurements are noisy and incomplete.

---

## Biological ageing

Ageing should be analysed at multiple levels rather than represented by one universal clock.

Possible future ageing dimensions include:

```text
Cellular age
Tissue age
Immune age
Vascular age
Skeletal age
Neural age
Metabolic age
Molecular age
Functional age
```

The system should track both the current state and the **trajectory**:

```text
T0 ----> T1 ----> T2 ----> T3
 |        |        |        |
state    state    state    state
 |        |        |        |
 +--------+--------+--------+
             |
             v
        biological trend
```

In many cases, the rate of change may be more informative than a single measurement.

---

## Abnormality and disease detection

The system should detect both known and potentially unknown abnormalities.

The intended architecture includes:

- anomaly detection;
- pathology classification;
- morphology analysis;
- cellular abnormalities;
- tissue abnormalities;
- molecular abnormalities;
- longitudinal change detection;
- multimodal disagreement detection.

An important research goal is **open-set anomaly detection**: the system should be able to identify observations that do not resemble known normal or known pathological patterns rather than forcing every observation into a predefined class.

The system should also be able to say **"insufficient evidence"** or **"additional measurement required"** instead of producing an unjustified confident prediction.

---

## Digital biological twin

A major long-term component is a **Digital Biological Twin**.

The digital twin is intended to represent the evolving state of an individual across time:

```text
                    DIGITAL BIOLOGICAL TWIN
                              |
       +----------------------+----------------------+
       |                      |                      |
     organs                 tissues                cells
       |                      |                      |
   function                morphology             state
       |                      |                      |
       +----------------------+----------------------+
                              |
                         molecular state
                              |
                        ageing trajectories
                              |
                         disease/risk state
                              |
                         interventions
                              |
                         uncertainty
```

A new examination should update the twin rather than exist as an isolated report.

```text
new measurement
      |
quality control
      |
modality analysis
      |
feature extraction
      |
compare with history
      |
update biological state
      |
detect changes
      |
risk assessment
      |
recommend next observation
```

---

## Intervention and rejuvenation research

A long-term goal is to study interventions intended to preserve or restore biological function. This includes research questions around cellular rejuvenation and other future interventions.

For example, partial cellular reprogramming involving **Yamanaka factors** is an area of scientific interest because cellular rejuvenation may potentially be accompanied by serious safety concerns, including loss of normal cellular identity and oncogenic/tumour risk.

`testHP` is intended to provide an architecture in which an intervention can be evaluated through separate monitoring channels:

```text
                    INTERVENTION
                         |
          +--------------+--------------+
          |              |              |
       efficacy        toxicity       safety
          |              |              |
          |        inflammation      genomic /
          |                         clonal changes
          |              |              |
          +--------------+--------------+
                         |
                    updated state
                         |
                  longitudinal follow-up
```

The system should distinguish **benefit monitoring** from **safety monitoring**. A change that looks beneficial in one modality must not automatically be considered safe overall.

This repository does **not** currently implement or recommend a rejuvenation therapy. The goal is to provide a research architecture for analysing biological state and, in the future, evaluating interventions under appropriate scientific and clinical validation.

---

## Current implementation

The project has now completed the first two architecture milestones.

### Stage 1 — Biological Data Core

The `core/` package defines the common data language used by analysis pipelines:

```text
core/
├── anatomy.py
├── biomarker.py
├── biological_state.py
├── measurement.py
├── observation.py
├── person.py
├── timepoint.py
└── uncertainty.py
```

The core connects measurements to a subject, timepoint, biological feature, anatomical location, provenance and uncertainty.

### Stage 2 — First end-to-end cell pipeline

A complete baseline pipeline now exists for cell-oriented image analysis:

```text
image
  ↓
segmentation
  ↓
cell instance mask
  ↓
CellAnalyzer
  ↓
cell features
  ↓
Measurement
  ↓
Observation
  ↓
BiologicalState
```

The implementation is split into:

```text
segmentation/
└── cell_segmentation.py

pipelines/
└── cell_pipeline.py
```

`segmentation/cell_segmentation.py` provides a simple NumPy-only threshold/connected-component baseline. It is deliberately not presented as a clinical or production-grade cell segmenter. The pipeline also accepts an externally generated instance mask, which allows future integration with Cellpose, StarDist or another validated segmentation model without changing the core data contract.

`pipelines/cell_pipeline.py` connects the existing `analysis/cell_analysis.py` implementation to the new biological data core. A single run creates measurements and observations for metrics such as:

- cell count;
- cell density;
- mean cell area;
- mean cell compactness;
- mean nearest-neighbour distance;
- cell distribution score.

Each output is associated with a subject, timepoint, anatomical location, modality, quality/confidence and processing version.

---

## Current analysis modules

The repository already contains several research-oriented analysis components:

```text
analysis/
├── aging_analysis.py
├── anomaly_analysis.py
├── cell_analysis.py
├── intervention_analysis.py
├── morphology_analysis.py
├── pathology_analysis.py
├── risk_analysis.py
├── rna_analysis.py
a└── tissue_analysis.py
```

These modules currently cover concepts such as:

- cell morphology and spatial statistics;
- tissue-level features;
- RNA expression statistics and dimensionality reduction;
- morphology abnormality scoring;
- ageing-related feature aggregation;
- anomaly interpretation;
- pathology prediction interpretation;
- risk aggregation;
- candidate intervention/monitoring actions.

At the current stage, many of these components are **prototypes and feature/score aggregators**, not clinically validated diagnostic models.

---

## Planned architecture

The project is moving toward a modular architecture similar to:

```text
acquisition/
    MRI
    microscopy
    histology
    omics
    laboratory
    wearable

preprocessing/

segmentation/
    organs
    tissues
    cells

biology/
    cells
    tissues
    organs
    systems

aging/
    clocks
    senescence
    trajectories

pathology/
    cancer
    infection
    inflammation
    degeneration

multimodal/
    embeddings
    fusion
    alignment

longitudinal/

digital_twin/

intervention/
    efficacy
    safety
    surveillance

decision/

validation/
```

The architecture is deliberately modular so that specialised models can be introduced without replacing the whole system.

---

## Core principles

### 1. Multimodality

No single measurement describes the whole organism.

### 2. Longitudinal analysis

The system should study change over time, not only isolated snapshots.

### 3. Hierarchical biology

Information should be connected across levels:

```text
molecule -> cell -> tissue -> organ -> system -> organism
```

### 4. Uncertainty

Every prediction should carry uncertainty and data-quality information where possible.

### 5. Safety first

A potentially beneficial change must always be evaluated against possible adverse effects.

### 6. Human and clinical oversight

The project is a research platform. Automated outputs should be treated as measurements, hypotheses, alerts or decision support until independently validated.

### 7. Reproducibility

Measurements should retain provenance, model versions, timestamps and processing information.

### 8. Unknowns are allowed

The system should be able to report uncertainty, conflicting evidence and previously unseen patterns.

---

## Long-term research roadmap

A practical development sequence is:

### Phase 1 — Biological data model

Create common representations for measurements, observations, tissues, organs, biomarkers, uncertainty and timepoints. **Completed.**

### Phase 2 — First modality pipeline

Connect a real analysis module to the common data model through an end-to-end cell pipeline. **Baseline completed.**

### Phase 3 — Multimodal integration

Combine independent observations into a coherent biological state.

### Phase 4 — Longitudinal modelling

Detect trends and rates of biological change.

### Phase 5 — Disease and ageing separation

Distinguish normal variation, ageing, pathology and measurement artefacts.

### Phase 6 — Digital Biological Twin

Maintain an evolving model of an individual's biological state.

### Phase 7 — Intervention monitoring

Measure both intended effects and safety signals following interventions.

### Phase 8 — Validation

Evaluate the system against high-quality datasets, longitudinal cohorts and appropriately designed prospective studies.

---

## Important limitations

`testHP` is currently a **research prototype**. It should not be used to diagnose disease, prescribe treatment, determine biological age for medical purposes, or make autonomous clinical decisions.

Several concepts described in the architecture are future goals rather than completed functionality. In particular, a complete multimodal fusion system, validated biological-age models, full longitudinal inference, digital-twin implementation and clinically validated intervention decision support are still development targets.

The 200-year lifespan objective is a long-term research vision, not a demonstrated outcome of the current software.

---

## Project status

**Stage:** early research / architecture prototype — Stages 1 and 2 implemented

The immediate technical priority is to establish reliable modality pipelines and connect them through the common biological data model.

The intended direction is:

```text
measure
  -> analyse
  -> integrate
  -> understand state
  -> detect change
  -> estimate risk
  -> decide what should be measured next
  -> update the model
  -> repeat
```

The ultimate goal is not simply to create an AI that predicts disease. It is to build a platform that can continuously build and update a **computational representation of human biological state**, enabling research into long-term health, ageing, disease prevention and biological rejuvenation.
